12-15 Molecular Diagnostics Overview
- Year Founded
-
2018
- Status
-
Private
- Employees
-
22
- Latest Deal Type
-
Later Stage VC
- Latest Deal Amount
-
$2.5M
- Investors
-
1
12-15 Molecular Diagnostics General Information
Description
Provider of an on-site, rapid response diagnostic device intended for detecting and differentiating between bacterial and viral infections using biofluids. The company's target applications include testing humans and farm animals for bacterial and viral Infections, as well as agricultural products, enabling the recognition of a specific complementary target ss-DNA/RNA in a sample and providing a useful electrical signal.
Contact Information
Website
www.12-15mds.comCorporate Office
- 37 Panagrossi Circle
- Suite L
- East Haven, CT 06512
- United States
Corporate Office
- 37 Panagrossi Circle
- Suite L
- East Haven, CT 06512
- United States
12-15 Molecular Diagnostics Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 1. Later Stage VC | 10-Feb-2022 | $2.5M | Completed | Generating Revenue |
12-15 Molecular Diagnostics Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Series A |
12-15 Molecular Diagnostics Patents
12-15 Molecular Diagnostics Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| WO-2026024616-A1 | Detection of pathogenic biomarker from plant tissues using tearing and steeping methods (tsm). | Pending | 22-Jul-2024 | ||
| WO-2025137451-A1 | Apparatus and method for detection of metal ions and peas pollutants in a sample | Inactive | 21-Dec-2023 | ||
| WO-2025054393-A1 | Method and device for detecting diseases, pathogens and parasites | Inactive | 08-Sep-2023 | ||
| US-12517084-B2 | Self disinfecting sensor and method of operation | Active | 20-Jan-2021 | ||
| US-20240077452-A1 | Self disinfecting sensor and method of operation | Active | 20-Jan-2021 | A61L2/04 |
12-15 Molecular Diagnostics Signals
12-15 Molecular Diagnostics Investors (1)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| CTW Venture Partners | Venture Capital | Minority |
12-15 Molecular Diagnostics FAQs
-
When was 12-15 Molecular Diagnostics founded?
12-15 Molecular Diagnostics was founded in 2018.
-
Where is 12-15 Molecular Diagnostics headquartered?
12-15 Molecular Diagnostics is headquartered in East Haven, CT.
-
What is the size of 12-15 Molecular Diagnostics?
12-15 Molecular Diagnostics has 22 total employees.
-
What industry is 12-15 Molecular Diagnostics in?
12-15 Molecular Diagnostics’s primary industry is Diagnostic Equipment.
-
Is 12-15 Molecular Diagnostics a private or public company?
12-15 Molecular Diagnostics is a Private company.
-
What is the current valuation of 12-15 Molecular Diagnostics?
The current valuation of 12-15 Molecular Diagnostics is .
-
What is 12-15 Molecular Diagnostics’s current revenue?
The current revenue for 12-15 Molecular Diagnostics is .
-
How much funding has 12-15 Molecular Diagnostics raised over time?
12-15 Molecular Diagnostics has raised $2.5M.
-
Who are 12-15 Molecular Diagnostics’s investors?
CTW Venture Partners has invested in 12-15 Molecular Diagnostics.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process